Suppr超能文献

溶酶体蛋白酶对大鼠肝脏果糖二磷酸醛缩酶的修饰作用。

Modification of rat liver fructose biphosphate aldolase by lysosomal proteinases.

作者信息

Katunuma N, Kominami E, Hashida S, Wakamatsu N

出版信息

Adv Enzyme Regul. 1982;20:337-50. doi: 10.1016/0065-2571(82)90024-3.

Abstract

In vivo proteolytic modification of liver aldolase on administration of leupeptin, a thiol proteinase inhibitor of microbial origin, is reported. When leupeptin was injected into rats, the activity of aldolase in the liver decreased to 40% of that in control rats. Molecular properties of aldolase isolated from the livers of control rats and leupeptin-treated rats indicated that a decrease of aldolase activity is attributable to hydrolysis of a peptide linkage(s) near the carboxyterminal of the enzyme. Injection of leupeptin also caused marked increase in the activities of free lysosomal proteinases, such as cathepsin A and cathepsin D and moderate increase of cathepsin B and cathepsin L. Increase in free activity of cathepsin A returned to the level of control rats by 12 hr after injection of leupeptin, whereas 36 hr was required for recovery of decreased aldolase activity. When insulin was coinjected with leupeptin, increase in the activity of free cathepsin A and decrease of activity of aldolase produced by the injection of leupeptin was prevented. These findings indicate that modification of aldolase may be due to action of a lysosomal protease(s). Incubation of the purified aldolase with the lysosomal fraction produced the same changes in properties of aldolase as those observed in vivo on injection of leupeptin. The aldolase inactivating proteinase in the lysosomal fraction was inhibited by PMSF and leupeptin and not by pepstatin. Purified cathepsin A (a serine proteinase), cathepsin B and cathepsin L (thiol proteinase) are potent inactivators of aldolase but cathepsin H and cathepsin D are not. Cathepsin A, B and L are involved in inactivation of aldolase in lysosomes. Endogenous thiol proteinase inhibitor which inhibits lysosomal thiol proteinases (cathepsin B, L and H) is found in the cytosol fraction of liver. The level of thiol proteinase inhibitor actually decreased to 60% of that in control rats in leupeptin-treated rats, suggesting that non-thiol proteinase cathepsin A is a major factor in inactivation of aldolase in lysosomes. Not only leupeptin but also other proteinase inhibitors (antipain, E-64-D, chloroquine) caused increase of labilization of the lysosomes and decrease in aldolase activity. Physiological stimuli which are known to induce the labilization of the lysosomal membrane, such as starvation and glucagon, caused slight or no significant increase of activities of free cathepsin A and D and resulted in no apparent change in aldolase activity.

摘要

据报道,在给予源自微生物的巯基蛋白酶抑制剂亮抑酶肽后,肝脏醛缩酶会发生体内蛋白水解修饰。当向大鼠注射亮抑酶肽时,肝脏中醛缩酶的活性降至对照大鼠的40%。从对照大鼠和经亮抑酶肽处理的大鼠肝脏中分离出的醛缩酶的分子特性表明,醛缩酶活性的降低归因于该酶羧基末端附近肽键的水解。注射亮抑酶肽还导致游离溶酶体蛋白酶(如组织蛋白酶A和组织蛋白酶D)的活性显著增加,组织蛋白酶B和组织蛋白酶L的活性适度增加。注射亮抑酶肽后12小时,组织蛋白酶A的游离活性恢复到对照大鼠的水平,而醛缩酶活性降低的恢复则需要36小时。当胰岛素与亮抑酶肽同时注射时,可防止因注射亮抑酶肽而导致的游离组织蛋白酶A活性增加和醛缩酶活性降低。这些发现表明,醛缩酶的修饰可能是由于溶酶体蛋白酶的作用。将纯化的醛缩酶与溶酶体部分一起孵育,会使醛缩酶的性质发生与注射亮抑酶肽后在体内观察到的相同变化。溶酶体部分中的醛缩酶失活蛋白酶受到苯甲基磺酰氟(PMSF)和亮抑酶肽的抑制,而不受胃蛋白酶抑制剂的抑制。纯化的组织蛋白酶A(一种丝氨酸蛋白酶)、组织蛋白酶B和组织蛋白酶L(巯基蛋白酶)是醛缩酶的有效失活剂,但组织蛋白酶H和组织蛋白酶D不是。组织蛋白酶A、B和L参与溶酶体中醛缩酶的失活。在肝脏的胞质溶胶部分中发现了抑制溶酶体巯基蛋白酶(组织蛋白酶B、L和H)的内源性巯基蛋白酶抑制剂。在经亮抑酶肽处理的大鼠中,巯基蛋白酶抑制剂的水平实际上降至对照大鼠的60%,这表明非巯基蛋白酶组织蛋白酶A是溶酶体中醛缩酶失活的主要因素。不仅亮抑酶肽,其他蛋白酶抑制剂(抗蛋白酶、E-64-D、氯喹)也会导致溶酶体的不稳定增加和醛缩酶活性降低。已知能诱导溶酶体膜不稳定的生理刺激,如饥饿和胰高血糖素,会导致游离组织蛋白酶A和D的活性轻微增加或无显著增加,并且醛缩酶活性没有明显变化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验